The Day In Review: Guidant Sues J & J Over Merger

November 7, 2005 -- Guidant took Johnson & Johnson to court, seeking to force the giant pharma to complete the merger the two companies agreed upon last December; Isotechnika said its lead drug met all endpoints in a Phase III psoriasis trial; Roche revealed its Tamiflu production capacity for the first time; Dendreon won fast track review status for Provenge, its prostate cancer vaccine; Kos Pharma in-licensed rights to Icatibant from Jerini of Germany; and Viropharma rose almost 15% after reporting its Q3 financial results. At the closing bell, the Centient Biotech 200™ was 7 points lower at 3847.45, a .19% decline.

MORE ON THIS TOPIC